ID   PIM1_RAT                Reviewed;         313 AA.
AC   P26794;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   24-JUL-2024, entry version 177.
DE   RecName: Full=Serine/threonine-protein kinase pim-1;
DE            EC=2.7.11.1;
GN   Name=Pim1; Synonyms=Pim-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Testis;
RX   PubMed=1620615; DOI=10.1093/nar/20.12.3183;
RA   Wingett D., Reeves R., Magnuson N.S.;
RT   "Characterization of the testes-specific pim-1 transcript in rat.";
RL   Nucleic Acids Res. 20:3183-3189(1992).
RN   [2]
RP   FUNCTION IN PHOSPHORYLATION OF CDC25A, AND INTERACTION WITH CDC25A.
RX   PubMed=10373478; DOI=10.1074/jbc.274.26.18659;
RA   Mochizuki T., Kitanaka C., Noguchi K., Muramatsu T., Asai A., Kuchino Y.;
RT   "Physical and functional interactions between Pim-1 kinase and Cdc25A
RT   phosphatase. Implications for the Pim-1-mediated activation of the c-Myc
RT   signaling pathway.";
RL   J. Biol. Chem. 274:18659-18666(1999).
CC   -!- FUNCTION: Proto-oncogene with serine/threonine kinase activity involved
CC       in cell survival and cell proliferation and thus providing a selective
CC       advantage in tumorigenesis. Exerts its oncogenic activity through: the
CC       regulation of MYC transcriptional activity, the regulation of cell
CC       cycle progression and by phosphorylation and inhibition of proapoptotic
CC       proteins (BAD, MAP3K5, FOXO3) (By similarity). Phosphorylation of MYC
CC       leads to an increase of MYC protein stability and thereby an increase
CC       of transcriptional activity. The stabilization of MYC exerted by PIM1
CC       might explain partly the strong synergism between these two oncogenes
CC       in tumorigenesis. Mediates survival signaling through phosphorylation
CC       of BAD, which induces release of the anti-apoptotic protein Bcl-
CC       X(L)/BCL2L1 (By similarity). Phosphorylation of MAP3K5, another
CC       proapoptotic protein, by PIM1, significantly decreases MAP3K5 kinase
CC       activity and inhibits MAP3K5-mediated phosphorylation of JNK and
CC       JNK/p38MAPK subsequently reducing caspase-3 activation and cell
CC       apoptosis. Stimulates cell cycle progression at the G1-S and G2-M
CC       transitions by phosphorylation of CDC25A and CDC25C. Phosphorylation of
CC       CDKN1A, a regulator of cell cycle progression at G1, results in the
CC       relocation of CDKN1A to the cytoplasm and enhanced CDKN1A protein
CC       stability. Promotes cell cycle progression and tumorigenesis by down-
CC       regulating expression of a regulator of cell cycle progression, CDKN1B,
CC       at both transcriptional and post-translational levels. Phosphorylation
CC       of CDKN1B, induces 14-3-3 proteins binding, nuclear export and
CC       proteasome-dependent degradation. May affect the structure or silencing
CC       of chromatin by phosphorylating HP1 gamma/CBX3 (By similarity). Acts
CC       also as a regulator of homing and migration of bone marrow cells
CC       involving functional interaction with the CXCL12-CXCR4 signaling axis
CC       (By similarity). Acts as a positive regulator of mTORC1 signaling by
CC       mediating phosphorylation and inhibition of DEPDC5 component of the
CC       GATOR1 complex. Acts as a negative regulator of innate immunity by
CC       mediating phosphorylation and inactivation of GBP1 in absence of
CC       infection: phosphorylation of GBP1 induces interaction with 14-3-3
CC       protein sigma (SFN) and retention in the cytosol (By similarity). Also
CC       phosphorylates and activates the ATP-binding cassette transporter
CC       ABCG2, allowing resistance to drugs through their excretion from cells
CC       (By similarity). Promotes brown adipocyte differentiation (By
CC       similarity). {ECO:0000250|UniProtKB:P06803,
CC       ECO:0000250|UniProtKB:P11309}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P11309};
CC   -!- SUBUNIT: Interacts with RP9 (By similarity). Interacts with HSP90AA1,
CC       this interaction stabilizes PIM1 protein levels. Interacts
CC       (ubiquitinated form) with HSP70 and promotes its proteasomal
CC       degradation (By similarity). {ECO:0000250|UniProtKB:P06803,
CC       ECO:0000250|UniProtKB:P11309}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Cell membrane {ECO:0000250}.
CC   -!- PTM: Autophosphorylated on both serine/threonine and tyrosine residues
CC       (By similarity). Phosphorylated. Interaction with PPP2CA promotes
CC       dephosphorylation (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated, leading to proteasomal degradation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. PIM subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63675; CAA45214.1; -; mRNA.
DR   PIR; S26298; S26298.
DR   RefSeq; NP_058730.1; NM_017034.1.
DR   AlphaFoldDB; P26794; -.
DR   SMR; P26794; -.
DR   STRING; 10116.ENSRNOP00000000637; -.
DR   PhosphoSitePlus; P26794; -.
DR   PaxDb; 10116-ENSRNOP00000000637; -.
DR   Ensembl; ENSRNOT00000000637.6; ENSRNOP00000000637.3; ENSRNOG00000000529.6.
DR   Ensembl; ENSRNOT00055011505; ENSRNOP00055009047; ENSRNOG00055006980.
DR   Ensembl; ENSRNOT00060005726; ENSRNOP00060004181; ENSRNOG00060003490.
DR   Ensembl; ENSRNOT00065046742; ENSRNOP00065038323; ENSRNOG00065027109.
DR   GeneID; 24649; -.
DR   KEGG; rno:24649; -.
DR   UCSC; RGD:3330; rat.
DR   AGR; RGD:3330; -.
DR   CTD; 5292; -.
DR   RGD; 3330; Pim1.
DR   eggNOG; KOG0583; Eukaryota.
DR   GeneTree; ENSGT00940000153394; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; P26794; -.
DR   OMA; GHRPCAD; -.
DR   OrthoDB; 4292089at2759; -.
DR   PhylomeDB; P26794; -.
DR   PRO; PR:P26794; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000000529; Expressed in testis and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0043024; F:ribosomal small subunit binding; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:1990748; P:cellular detoxification; ISS:UniProtKB.
DR   GO; GO:0071346; P:cellular response to type II interferon; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045824; P:negative regulation of innate immune response; ISS:UniProtKB.
DR   GO; GO:0090336; P:positive regulation of brown fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISO:RGD.
DR   GO; GO:1905062; P:positive regulation of cardioblast proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:1904263; P:positive regulation of TORC1 signaling; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:1902033; P:regulation of hematopoietic stem cell proliferation; ISO:RGD.
DR   GO; GO:0022898; P:regulation of transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0070561; P:vitamin D receptor signaling pathway; ISO:RGD.
DR   CDD; cd14100; STKc_PIM1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017348; PIM1/2/3.
DR   InterPro; IPR051138; PIM_Ser/Thr_kinase.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22984; SERINE/THREONINE-PROTEIN KINASE PIM; 1.
DR   PANTHER; PTHR22984:SF29; SERINE_THREONINE-PROTEIN KINASE PIM-1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037993; STPK_Pim-1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Cell cycle; Cell membrane; Cytoplasm; Kinase;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Proto-oncogene; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN           1..313
FT                   /note="Serine/threonine-protein kinase pim-1"
FT                   /id="PRO_0000086530"
FT   DOMAIN          38..290
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        167
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         44..52
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         67
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         121
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         128
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11309"
FT   MOD_RES         98
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11309"
FT   MOD_RES         261
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11309"
SQ   SEQUENCE   313 AA;  35631 MW;  D5757DA9F1821BF9 CRC64;
     MLLSKINSLA HLRAAPCNDL HANKLAPGKE KEPLESQYQV GPLLGSGGFG SVYSGIRVAD
     NLPVAIKHVE KDRISDWGEL PNGTRVPMEV VLLKKVSSGF SGVIRLLDWF ERPDSFVLIL
     ERPEPVQDLF DFITERGALQ EELARSFFWQ VLEAVRHCHN CGVLHRDIKD ENILIDLNRG
     ELKLIDFGSG ALLKDTVYTD FDGTRVYSPP EWIRYHRYHG RSAAVWSLGI LLYDMVCGDI
     PFEHDEEIVK GQVYFRQRVS SECQHLIRWC LSLRPSDRPS FEEIQNHPWM QDVLLPQATA
     EIHLHSLSPS PSK
//
